Intralesional bleomycin as alternative therapy in the treatment of multiple basal cell carcinomas

Dermatol Online J. 2006 Mar 30;12(3):25.

Abstract

An 82-year-old female with with multiple basal cell carcinomas is presented. Her history includes treatment for similar lesions for 15 years with surgical and X-ray methods. We injected intralesional bleomycin to eight new histologically proven basal cell cancers. A followup at 2 years demonstrates the effectiveness of this therapy.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Antimetabolites, Antineoplastic / administration & dosage*
  • Antimetabolites, Antineoplastic / therapeutic use
  • Basal Cell Carcinoma / drug therapy*
  • Basal Cell Carcinoma / pathology
  • Bleomycin / administration & dosage*
  • Bleomycin / therapeutic use
  • Female
  • Humans
  • Injections, Intralesional
  • Neoplasms, Second Primary / drug therapy*
  • Neoplasms, Second Primary / pathology
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Bleomycin